Fig. 6

30-year cumulative risks (%) of developing incident CVD for example early-stage Hodgkin lymphoma patients, by sex, age at treatment, and type of treatment. The standard treatment for early-stage Hodgkin lymphoma is anthracycline-based chemotherapy. In addition, the areas of disease may be treated by radiotherapy. The figure shows the cumulative risks of CVD for four example patients receiving identical treatments for Hodgkin lymphoma [19]. The only difference between the patients is their age at treatment and their sex. The decision that the oncologist must make for individual patients is whether the increased risk of CVD is outweighed by the added benefit of the radiotherapy for disease control. CVD rates were obtained using Method A1 and are shown in Fig. 3 and Table e2. Competing risks were taken into account. Further details are given in Additional Text e1